Serviksin invaziv skuamöz hücreli karsinomlarında HPV'nin PCR ve immünohistokimyasal yöntemlerle belirlenmesi
Birçok epidemiyolojik klinikopatolojik ve moleküler çalışmalar çoğu servikal kanser prekürsör lejyonlarının patogenezinde human papilloma virüsün (HPV) varlığını ortaya koymuştur. Moleküler biyolojik tekniklerden polimeraz zincir reaksiyonu (PCR) oldukça duyarlı bir yöntemdir. Servikse ait örneklerde HPV yi belirlemede kullanılan bir başka yöntem de immünohistokimyasal (İHK) yöntemdir. Çalışmamızda serviksin invaziv skuamöz hücreli karsinomlarmda (İSHK), PCR ve İHK yöntemi kullanarak HPV insidansını belirlemekve bulunan HPV tipleri ile histolojik tip arasındaki korelasyonu incelemeyi amaçladık. Kliniğimizde İSHK tanısı almış 26 vaka PCR yöntemiyle hem HPV varlığı hem de HPV tipleri açısından; ayrıca İHK olarak HPV varlığı yönünden BSA-peroksidaz (DAB) yöntemiyle incelendi. Olgularımızda PCR yöntemiyle HPV 16 yi %23, HPV18'i %U.5, HPV33'ü % 4, HPV16+33'ü (mikst enfeksiyon) %4 oranında belirledik. HPV 6 ve IVi hiçbir olguda tespit etmedik. 26 olgumuzda İHK yöntemle % 30.5 oranında HPV pozitivitesi saptadık. PCR ile (-) bulduğumuz 15 olgudan 5'inde İHK ile HPV tespit ettik. PCR ve/veya İHK yöntemiyle HPV pozitivitesi saptadığımız olguların oranı %61.5' di. Histolojik tipleri PCR yöntemi ile bulduğumuz HPV tipleri ile karşılaştırdığımızda büyük hücreli keratinize karsinomların (BHKK) % 18'ni HPV 16 (+), % 18'ni HPV 18 (+), % 9 'nu HPV33 (+), %9'nu HPV 16+33 (+), % 46'sını HPV(-) tespit ettik. Büyük hücreli nonkeratinize karsinomların (BHNKK) % 13'üHPV16(+), %18' i HPV 18 (+), % 69'u HPV(-); küçük hücreli karsinomların (KHK) % 50'si HPV16(+), % 50'si HPV(-) di. İHK olarak pozitif olguların histolojik tip dağılımını incelediğimizde % 37.5'ni BHKK %62.5'ni BHNKK olarak belirledik. Yaptığımız çalışmada servikal karsinomlarda HPV'nin rolü ve insidansının dünya çapındaki bulgularla kesin benzerlikler gösterdiğini ve tarama programlarının önemini vurgulamaya çalıştık.
Determination of HPV by PCR and immunohistochemistry in cervival invasive squamous cell carcinoma
Many epidemiological, clinicopaihological and molecular studies have shown the role of human papilloma virus (HPV) in the pathogenesis of the cervical carcinoma precursor lesions. Polimerase chain reaction (PCR), is very sensitive method for its establishment. Another method to identify HPV in cervival samples is immunohistochemistry (IHC). In this study, we aimed to determine HPV incidence in cervical invasive squamous cell carcinoma (ISCC) by using PCR and IHC and to investigate the correlation between HPV types and histological types. In our pathology department, 26 cases are investigated for HPV presence and types by PCR method. They are evaluated for HPV presence immunohistochemically by BSA-peroxidase (DAB) method. By PCR we found HPV 16 in 23%, 18 in 11.5%, 33 in 4%, 16+33 (mixt infection) in 4% of the cases. We didn't show HPV 6 and 11 in any of the cases. HPV positivity was 30.5%, immunohistochemically. In 5 of the 15 cases that were found to be negative by PCR, HPV was shown by IHC. The percentage of the cases proven to be HPV positive by PCR and/or IHC was 61.5%. When we compared the histological types with HPV types established by PCR, 18% of large cell keratinizing carcinoma (LCKC) was HPV 16 (+), 18% was 18 (+), 9% was 33 (+), 9% was 16+33 (+) and 46% was HPV(-); whereas 13% of large cell non-keratinizing carcinoma (LCNKC) was HPV 16(+), 18% was 18 (+), 69% was HPV(-) and 50% of small cell carcinoma was HPV 16(+), 50% was HPV(-). When we evaluated the histological type distribution oflHC-proven HPV positive cases, 37.5% was LCKC and 62.5% was LCNKC. We find the role and incidence of HPV in cervical carcinoma cases in our country comparable to global evidence; we conclude with the importance of screening programmes.
___
- Huang LW, Chao SL, Chen PH, et al. Multiple
HPV genotypes in cervical carcinomas:
improved DNA detection and typing in archival
tissues. Journal of Clinical Virology 2004; 29:
271-276
- Kaufmann AM, Stern PL, Rankin EM, et al
- Safety and immunogenicity of TA-HPV, a
recombinant vaccinia virus expressing modified
human papillomavirus (HPV)-16 and HPV-18
E6 and E7 genes, in women with progressive
cervical cancer. Clinical Cancer Research
2002; 8:3676-3685
- Kurman RJ. Precancerous lesions of the
cervix, Chapter 7, Carcinoma and other tumors
of the cervix, Chapter 8, in: Blausteirfs
Pathology of the Female Genital Tract, Springer
Verlag, New York, 1994; 4th ed. pp: 229-299
- Fax H, Wells M, Longocre TA, et al
- Premalignant and malignant squamous lesions
of the cervix, Chapter 7, in: Obstetrical and
Gynaecological Pathology, Churcill Livingstone,
New York, 1995; 4th ed, pp: 273-322
- Karaloğlu D, Tazıcı H, et al. Detection of
HPV 16 and HPV 18 infection in patients with
cervical neoplasia. Eur J Gynaec Oncol 1996;
17(4): 296-298
- Iwasawa A, Nieminen P, Lehtinen M, et al
- Human papilomavirus DNA in uterine cervix
squamous cell carcinoma and adenocarcinoma
detected by polymerase chain reaction. Cancer
1996; 77:2275-2279
- Bonfiglio TA, Erozan YS. The biology of
human papillomaviruses and their role in
cervical carcinogenesis, Chapter 5, in:
Gynaecologic Cytopathology. Lippincott-Raven,
Philadelphia. 1997; pp: 51-72
- Nakagawa S, Yoshikawa H, et al. Type of
human papillomavirus is related to clinical
features of cervical carcinoma. Cancer 1996;
78(9): 1935-1941
- Wilczynski SP, Bergen S, et al. Human
papillomaviruses and cervical cancer: Analysis
of histopathologic features associated with
different viral types. Hum Pathol. 1988; 19(6):
697-704
- Huang S, Afonina I, et al. Human
papillomaviruses types 52 and 58 prevalent in
cervical cancers from Chinese women. Int J
Cancer 1997; 70. 408-411
- Bommel P, Brule A, et al. HPV DNA
presence and HPV genotypes as prognostic
factors in low-stage squamous cell cervical
cancer. Gynec Oncol 1993; 48: 333-337
- Chen TM, Chen CA, et al. The genotypes
and prognostic significance of human
papillomaviruses in cervical cancer. Int J cancer
1994; 57:181-184
- Kraus I, Molden T, Erno LE, et al. Human
papillomavirus oncogenic expression
in the dysplastic portio; an investigation of
biopsies from 190 cervical cones. British
Journal of Cancer 2004; 90: 1407-1413
- Matsukura T, Sugase M. Human
papillomavirus genomes in squamous cell
carcinomas of the uterine cervix. Virology 2004;
324:439-449
- Bachtıary B, Obermair A, Dreier B, et
al.Impact of multiple HPV İnfection on response
to treatment and survival in patients receiving
radical radiotherapy for cervical cancer. Int
- J. Cancer 2002; 102:237-243
- Combita AL, Bravo MM, Touze A, et. al
- Serologic response to human oncogenic
papillomavirus types 16,18,31,33,39,58 and
59 virus-like particles in Colombian women
with invasive cervical cancer. Int J. Cancer
2002; 97: 796-803
- Aksoy F, Seçkin S. Human papillomavirüs
enfeksiyonu ve serviks neoplazileri. Ankara
Patoloji bülteni 1992; 9(1): 89-91
- Delvenne P, Fontaine MA, et al. Detection
of human papillomaviruses in parafin-
embedded biopsies of cervical intraepithelial
lesions: Analysis by immunohistochemistry, in
situ hybridization and the polymerase chain
reaction. Mod Pathol 1994; 7: 113-119
- Konno R, Sato S, Yajima A. Progression of
isquamous cell carcinoma of the uterine cervix
from cervical intraepithelial neoplasia infected
with human papillomavirus. A retrospective
follow-up study by in situ hybridization and
polymerase chain reaction. Int J Gynec 1992;
11:105-112
- Zehbe I, Wilander E. Human papillomavirus
infection and invasive cervical neoplasia: A
study of prevalence and morphology. J Pathol
1997; 181:270-275
- Vural G, Tüfekçi C, et al. Türkiye'de yüksek
risk içeren bir grupta HPV sıklığı. Jinekoloji
ve Obstetrik Dergisi. 1995; 9: 201-204
- Song YS, Kee SH, et al. Major sequence
variants in E7 gene of human papillomavirus
type 16 from cervical cancerous and
noncancerous lesions of Korean women. Gynec
Oncol 1997; 66:275-281
- Kristensen GB, Karlsen F, et al. Human
papillomavirus has no prognostic significance
in cervical carcinoma. Eur J Cancer 1996;
32A(8): 1349-1353
- Rosai J. Female Reproductive System,
Chapter 19, inAckermanxs Surgical Pathology,
ed Rosai J. St. Louis, Mosby, 2004; 9th ed
- pp:1483-1762
- Einstein BI. The polymerase chain reaction: A
new method of using molecular genetics for medical
diagnosis. N E J Med 1990; 322: 178-183
- Sasagawa T, Minemoto Y, Basha W, et al
- A New PCR-based assay amplifies the E6-E7
genes of most mucosal human papillomavirus
(HPV). Virus Research 2000; 67: 127-139
- Kadish AS, Ho GYF, et al
- Lymphoproliferative responses to human
papillomavirus (HPV) type 16 proteins E6 and
E7: Outcome of HPV infection and associated
neoplasia. J Nat Can Inst 1997; 89(17): 1285-
1292
- Güner H, Barlas MN. Jinekolojik
neoplazüerde viral enfeksiyonların yeri ve klinik
önemi. Türkiye Klinikleri Jinekoloji Obstetrik
Dergisi 1994;.4(2): 67-73
- Koutsky L, Holmes KK, et al. A cohort
study of the risk of cervical intraepithelial
neoplasia grade 2 or 3 in relation to
papillomavirus infection. New Eng J Med 1992;
29:1272-1278
- Dillner J, Lehtinen M, et al. Prospective
seroepidemiologic study of human
papillomavirus infection as a risk factor for
invasive cervical cancer. J Nat Can Inst 1997;
89(17): 1293-1299
- Lorincz A, Reid R, et al. Human
papillomavirus infection of the cervix: Relative
risk associations of 15 common anogenital
types. Obst Gynecol 1992; 79(3): 328-337
- Resnick RM, Cornelissen MTE, et al
- Detection and typing of human papillomavirus
in archival cervical cancer specimens by DNA
amplification with consensus primers. J Nat
Cancer Inst 1990; 82(18): 1477-1484
- Sato S, Takashi O, et al. Sensitivity of
koilocytosis, immunohistochemistry and
electron microscopy as compared to DNA
hybridization in detecting human
papillomavirus in cervical and vaginal
condyloma and intraepithelial neoplasia. Int
J Gynec Pathol 1986; 5(4): 297-307
- Gomez F, Abad MM, Munoz E, et al. Study
of infection by human papillomavirus in severe
dysplasia and in situ hybridization. Eur J
Histochem 1992; 36:137-142
- Schadendorf D, Tiedemann KH, et
al.Detection of human papillomavirus in
paraffin-embedded condylomata acuminata-
comparison of immunohistochemistry, in situ
hybridization and polymerase chain reaction
- J Inves Der 1991; 97(3): 549-554
- Basu S, Mitra PK, et al. Detection of human
papillomavirus in cervical swabs from Indian
women by cytological and immunocytochemical
technique. Neoplasma 1991; 38(6): 639-644
- Toki T, Oikawa N, et al. Immunohistoc
hemical and electron microscopic demonstra
tion of human papillomavirus in dysplasia of
the uterine cervix. Tohoku J Exp Med 1986;
149:163-167
- Bose S, Choudhuri M, et al
- Immunohisto chemical demonstration of the
simultaneous presence of herpes simplex virus
type-2 and. human papillomavirus antigens in
patients with carcinoma of the uterine cervix
- Med Sci Res 1988; 16: 905-906
- Syrjanen KJ. Human papillomavirus lesions
in association with cervical dysplasias and
neoplasias.Obst Gynec 1983; 62(5): 617-624
- Reid R, Crum P, et al. Genital warts and
cervical cancer. III. Subclinical papillomavirus
infection and cervical neoplasia are linked by
a spectrum of continuous morphologic and
biologic change. Cancer 1984; 943-953
- Benda JA. Pathology of cervical carcinoma
and its prognostic implications. Semin Oncol
1994; 21(1): 3-11